Myo-Inositol for PCOS: The Dose, and the Honest Grade
The dose used in most myo-inositol PCOS trials is 4 g a day, usually 2 g twice daily, and myo-inositol on its own rather than D-chiro-inositol on its own. Be clear about how strong that evidence is: the 2023 international PCOS guideline recommends inositol only CONDITIONALLY, on evidence it rates VERY LOW quality, and says no specific type, dose or combination can currently be recommended. Insulin measures and free testosterone do move. Ovulation, weight and hirsutism are uncertain or unfavourable. Educational only, not medical advice, and PCOS must be diagnosed by a clinician.
Get PCOS confirmed by a clinician before you treat it PCOS is a diagnosis of exclusion. Thyroid disease, high prolactin, non-classic congenital adrenal hyperplasia and androgen-secreting tumours can all look like it, and the assessment involves cycle history, androgens, thyroid and prolactin. This page is not a diagnosis and cannot be used as one.
Self-treating an undiagnosed cause of androgen excess delays finding the real one, and some of the alternatives are serious. The diagnostic criteria and the workup are set out in the international guideline.
Take 2 g of myo-inositol twice a day, 4 g in total 4 g a day is the dose most myo-inositol PCOS trials used, taken as 2 g twice daily in water. Trials ran myo-inositol alone at 1 to 4 g a day, most at 4 g, and myo-inositol plus folic acid at 2 to 4 g with 200 to 400 mcg of folic acid. This is the dose Lara Briden gives in her own write-up as well.
Myo-inositol acts as a second messenger for insulin and FSH signalling, which is why the insulin measures are where its evidence is strongest. Pooled against placebo, HOMA-IR fell by about 1.14 points.
Do not take D-chiro-inositol on its own If you buy a blend, the ratio to look for is 40 parts myo-inositol to 1 part D-chiro-inositol. Understand that this specific ratio rests on very low certainty evidence: it comes from physiological reasoning and mouse models, plus two small human trials comparing ratios. Plain myo-inositol on its own is the better-supported choice.
The umbrella review advises that D-chiro-inositol on its own should be used with caution, and the D-chiro-only trials are where BMI moved in the wrong direction. The 2023 guideline is explicit that no specific type, dose or combination of inositol can currently be recommended.
Give it six months before you decide it works Myo-inositol trials in PCOS ran primarily for six months. Three months is the practical floor Lara Briden uses in her own practice, and that is her clinical opinion rather than a trial threshold, so treat six months as the real read-out point.
Hormonal and metabolic change accrues over months. A four-week verdict on this is a verdict on nothing.
Track your cycle, not the scale Log cycle length and whether you are ovulating, and review it with your clinician at six months. If unwanted hair growth or central weight gain is your main concern, ask specifically whether metformin is the better fit for you, because the guideline puts metformin ahead of inositol for both.
The cycle and insulin measures are where the signal actually is. Body weight is not: pooled BMI slightly favoured placebo, so judging this by the scale will mislead you in both directions.
Evidence check, the guideline: a conditional yes, on very low quality evidence The 2023 International Evidence-based Guideline gives inositol a CONDITIONAL recommendation with evidence quality rated VERY LOW. Its own wording is that inositol could be considered based on individual preferences and values, noting limited harm and potential improvement in metabolic measures, yet limited clinical benefits including in ovulation, hirsutism or weight. A separate practice point says no specific type, dose or combination can currently be recommended.
This is the single most important line on the page and it cuts both ways. A major guideline reviewed everything and did not say no. It also did not say this works. Anyone selling you inositol as proven for PCOS is going past what the people who read all the trials were willing to write.
Evidence check, the markers move and the outcomes do not follow Against placebo, the metabolic and androgen markers do move: HOMA-IR down about 1.14 points, free testosterone down about 0.46, SHBG up. The outcomes are a different picture. Ovulation is supported only at low certainty. Pooled BMI slightly FAVOURED placebo (mean difference 0.67, 95% CI 0.10 to 1.23). Hirsutism was better on metformin. A 2026 umbrella review of 13 meta-analyses graded 85 outcomes and found NO high-quality evidence among them: about 19 percent moderate, 40 percent low, 41 percent very low.
A marker moving is a mechanism working. It is not the same as the thing you came for changing. Publishing the gap between the two is the honest version of this supplement.
Evidence check, versus metformin: a draw on most things, and much easier on the gut Head to head, myo-inositol and metformin came out level on most reproductive and hormonal endpoints, including menstrual regularity (odds ratio 1.85, 95% CI 0.68 to 5.01) at MODERATE certainty and clinical pregnancy (odds ratio 1.18, 95% CI 0.79 to 1.78) at moderate certainty. Metformin was better for hirsutism and waist-to-hip ratio. Myo-inositol was clearly better tolerated: gastrointestinal side effects were far less common (odds ratio 0.09, 95% CI 0.02 to 0.37), also at moderate certainty.
This is the strongest evidence on the page, and note what it is evidence OF. The tolerability difference is well established. It is not a finding that inositol works better; it is a finding that on several endpoints the two are hard to tell apart. Which one is right for you is a prescriber's call, not ours.
Evidence check, fertility: Cochrane is openly uncertain, so do not plan around it The Cochrane review of inositol for subfertile women with PCOS pooled 13 randomized trials in 1,472 women and concluded, in its own words, that in light of available evidence of very low quality it is uncertain whether myo-inositol improves live birth rate or clinical pregnancy rate. Live birth odds ratio 2.42 with a 95 percent confidence interval from 0.75 to 7.83, which crosses no effect. It has not been updated since 2018.
This is the claim inositol is most often sold on to people trying to conceive, and it is the claim with the least behind it. If conception is the goal, that is a conversation with a fertility clinician, and inositol is not a substitute for one.
Myo-inositol is a second messenger in insulin and FSH signalling, which is the mechanism behind every claim made for it in PCOS: improve insulin signalling, lower the androgen drive, and let ovulation resume.
View sources
Inositol for mood, sleep, and PCOS (Lara Briden, episode 9)
Inositol for mood, sleep, and PCOS (polycystic ovary syndrome)
Inositol for Mood, Sleep, and PCOS (Polycystic Ovary Syndrome), Lara Briden
2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome (Teede et al., European Journal of Endocrinology, 2023)
Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-Based PCOS Guidelines (Fitz et al., JCEM, 2024)
Inositol for subfertile women with polycystic ovary syndrome (Showell et al., Cochrane Database of Systematic Reviews, 2018)
Effects of inositol in women with PCOS: an umbrella review of meta-analyses from randomized controlled trials (Duan et al., Frontiers in Endocrinology, 2026)
Inositol safety: clinical evidences (Carlomagno and Unfer, European Review for Medical and Pharmacological Sciences, 2011)
Not medical advice. This page is for education only and is not a substitute for professional medical care. Consult a qualified clinician before changing your health routine.
Independent curation. YourProtocol is an independent platform. This protocol is based on the publicly available work of Lara Briden and is not created, reviewed, endorsed by, or affiliated with Lara Briden or Naturopathic Doctor (ND); Christchurch, New Zealand.
Is this for you
- Anyone with a clinician-confirmed PCOS diagnosis deciding whether inositol is worth trying
- People who have been sold inositol as proven for PCOS and want to see the actual guideline wording
- Anyone weighing inositol against metformin, or wondering whether to take both questions to their doctor
- People trying to conceive who want an honest read on what the fertility evidence does and does not show
- Not for you if PCOS has not been diagnosed yet: the first step is a clinician, not a supplement
Cautions
- Educational only, not medical advice, and not a diagnosis. PCOS must be diagnosed by a clinician, and several other conditions produce the same picture.
- The independent evidence is genuinely uncertain. The 2023 international guideline recommends inositol only conditionally, on evidence it rates very low quality, and explicitly notes limited clinical benefits including in ovulation, hirsutism or weight.
- Do not expect weight loss. Pooled BMI data slightly favoured placebo, and metformin outperformed inositol on central adiposity. Lara Briden's own write-up says inositol promotes weight loss; the pooled trial evidence does not support that and we do not repeat it.
- If you are pregnant or trying to conceive, this is a clinician decision. Myo-inositol has been used in antenatal trials without a harm signal, but the 2023 Cochrane review rated that evidence low to very low certainty and called for better reporting of potential harms. It is not established as proven safe in pregnancy, and Lara Briden's stronger wording on this goes past the evidence.
- If you take metformin, insulin or any glucose-lowering medication, tell your prescriber before adding inositol. No documented interaction has been established either way, and an additive glucose-lowering effect is plausible and unmonitored.
- Gastrointestinal effects (nausea, gas, loose stools) show up mainly at doses around 12 g a day, well above the 4 g used here. If they appear, lower the dose and speak to your clinician.
- Inositol supplements are not held to pharmaceutical quality control or dosing consistency, a point the guideline itself makes. Third-party testing is worth paying for.
- Lara Briden is a Doctor of Naturopathic Medicine (ND), not an MD or endocrinologist. Her disclosable interest is book sales; we found no supplement line, dispensary or affiliate relationship with any inositol brand.
Common questions
Some links earn us a commission. It never affects our picks or grades. See our affiliate disclosure.